We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Horace Mann Educators
HMN
$2.1B
| $264K | ﹤0.01% |
9,120
-26,800
| -75% | -$774K |
|
777
SIGA Technologies
SIGA
$223M
| $263K | ﹤0.01% |
84,989
+7,820
| +10% | +$25.9K |
|
|
NAUH
778
DELISTED
National American University Holdings, Inc.
NAUH
| $261K | ﹤0.01% |
67,073
+8,618
| +15% | +$32K |
|
|
FISV
779
Fiserv Inc
FISV
$27.2B
| $260K | ﹤0.01% |
9,160
-30,300
| -77% | -$867K |
|
|
MFI
780
DELISTED
MICROFINANCIAL INC
MFI
| $256K | ﹤0.01% |
32,484
+9,763
| +43% | +$80.8K |
|
|
EMKR
781
DELISTED
Emcore Corp
EMKR
| $255K | ﹤0.01% |
+5,040
| New | +$250K |
|
|
CYN
782
DELISTED
CITY NATIONAL CORPORATION
CYN
| $252K | ﹤0.01% |
+3,200
| New | +$241K |
|
783
Altimmune
ALT
$539M
| $248K | ﹤0.01% |
451
+342
| +314% | +$200K |
|
784
Gibraltar Industries
ROCK
$1.34B
| $244K | ﹤0.01% |
+12,941
| New | +$235K |
|
|
FRTX
785
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $244K | ﹤0.01% |
+60
| New | +$268K |
|
|
PRO
786
DELISTED
PROS Holdings
PRO
| $243K | ﹤0.01% |
7,720
-19,788
| -72% | -$717K |
|
|
OPLK
787
DELISTED
OPLINK COMMUNICATIONS INC
OPLK
| $243K | ﹤0.01% |
13,552
-20,446
| -60% | -$363K |
|
|
DSPG
788
DELISTED
DSP Group Inc
DSPG
| $242K | ﹤0.01% |
28,006
-37,800
| -57% | -$343K |
|
789
Achieve Life Sciences
ACHV
$626M
| $241K | ﹤0.01% |
9
+2
| +29% | +$49.1K |
|
|
DZSI
790
DELISTED
DZS Inc. Common Stock
DZSI
| $241K | ﹤0.01% |
+11,404
| New | +$258K |
|
791
TTEC Holdings
TTEC
$103M
| $235K | ﹤0.01% |
+9,600
| New | +$222K |
|
|
WFM
792
DELISTED
Whole Foods Market Inc
WFM
| $235K | ﹤0.01% |
4,640
-71,414
| -94% | -$3.8M |
|
793
Travelzoo
TZOO
$103M
| $234K | ﹤0.01% |
10,210
-6,200
| -38% | -$141K |
|
|
PCMI
794
DELISTED
PCM, Inc
PCMI
| $233K | ﹤0.01% |
+23,828
| New | +$242K |
|
|
AMRS
795
DELISTED
Amyris Inc.
AMRS
| $232K | ﹤0.01% |
4,144
+2,436
| +143% | +$153K |
|
796
Bank of Marin Bancorp
BMRC
$466M
| $231K | ﹤0.01% |
+10,246
| New | +$226K |
|
|
WMAR
797
DELISTED
West Marine Inc
WMAR
| $228K | ﹤0.01% |
+20,078
| New | +$252K |
|
|
GFIG
798
DELISTED
GFI GROUP INC
GFIG
| $227K | ﹤0.01% |
+63,845
| New | +$248K |
|
799
Clearwater Paper
CLW
$271M
| $226K | ﹤0.01% |
+3,600
| New | +$214K |
|
800
ePlus
PLUS
$2.33B
| $226K | ﹤0.01% |
16,236
-6,280
| -28% | -$88.4K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.